Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
Heavy Snowfall Transforms Kashmir Valley After Dry Spell
Wenger defends Club WC format
Reuters Europe’s Nordic spaceports reduce U.S. satellite dependency
Smart Wearables Now Monitor Heart, Glucose, Sleep in Real Time; Health Insurance Sector Takes Note
Floods kill eight at Nepal China border Friendship Bridge collapse
